TECH Stock Financial Analysis - Bio-Techne Corporation (NasdaqGS) Stock

Overview

Bio-Techne Corporation is a leading biotechnology company based in the United States, specializing in the development and manufacturing of high-quality purified proteins and custom reagent solutions. Primarily operating within the life sciences sector, the company's core focus encompasses various areas such as protein biology, antibodies, and immunoassays. Bio-Techne is renowned for its innovative approach in products development that broadly supports the research, diagnostics, and bioprocessing communities. Key projects include the development of advanced diagnostics through its ProteinSimple brand, which provides proprietary systems for protein analysis, and the Novus Biologicals platform, offering an extensive portfolio of antibodies and reagents. These initiatives illustrate Bio-Techne’s commitment to facilitating scientific discovery and enhancing healthcare outcomes.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Bio-Techne Corporation as of June 30, 2025 is 1,219.63 MM.
The operating income for Bio-Techne Corporation as of June 30, 2025 is 265.24 MM.
The net income for Bio-Techne Corporation as of June 30, 2025 is 73.40 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	1,219.63	265.24	73.40
2025-03-31	1,208.77	224.71	131.67
2024-12-31	1,196.02	245.54	158.14
2024-09-30	1,171.58	243.81	150.71
2024-06-30	1,159.06	248.61	168.10
2024-03-31	1,154.28	254.21	203.00
2023-12-31	1,145.00	250.86	224.16
2023-09-30	1,143.98	276.00	246.70
2023-06-30	1,136.70	281.11	285.26
2023-03-31	1,123.61	258.31	271.30
2022-12-31	1,119.84	283.58	261.82
2022-09-30	1,117.54	275.70	291.99
2022-06-30	1,105.60	279.06	272.05
2022-03-31	1,076.40	289.40	225.49
2021-12-31	1,029.58	271.69	210.53
2021-09-30	984.55	259.31	176.63
2021-06-30	931.03	251.40	140.41
2021-03-31	847.84	207.64	184.29
2020-12-31	798.97	184.68	174.95
2020-09-30	759.65	165.96	248.29

Income Statement: EPS

The earnings per share basic for Bio-Techne Corporation as of June 30, 2025 is 0.47.
The earnings per share diluted for Bio-Techne Corporation as of June 30, 2025 is 0.46.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30	0.47	0.46
2025-03-31	0.83	0.83
2024-12-31	1.00	0.98
2024-09-30	0.95	0.95
2024-06-30	1.07	1.05
2024-03-31	1.29	1.25
2023-12-31	1.42	1.39
2023-09-30	1.57	1.52
2023-06-30	1.81	1.76
2023-03-31	1.73	1.68
2022-12-31	1.67	1.61
2022-09-30	1.86	1.79
2022-06-30	1.73	1.66
2022-03-31	1.44	1.37
2021-12-31	1.35	1.29
2021-09-30	1.13	1.08
2021-06-30	0.91	0.87
2021-03-31	1.19	1.15
2020-12-31	1.14	1.10
2020-09-30	1.62	1.57

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Bio-Techne Corporation as of June 30, 2025 is 287.56 MM.
The cash from investing activities for Bio-Techne Corporation as of June 30, 2025 is -35.18 MM.
The cash from financing activities for Bio-Techne Corporation as of June 30, 2025 is -253.91 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	287.56	-35.18	-253.91
2025-03-31	264.85	-44.40	-223.55
2024-12-31	304.72	-51.97	-207.92
2024-09-30	303.49	-70.60	-205.48
2024-06-30	298.98	-203.03	-122.40
2024-03-31	306.88	-198.98	-86.53
2023-12-31	276.43	-423.63	116.73
2023-09-30	257.69	-400.07	125.93
2023-06-30	254.39	-265.65	22.62
2023-03-31	273.72	-279.46	-18.89
2022-12-31	296.31	-74.36	-253.79
2022-09-30	332.92	-109.42	-234.97
2022-06-30	325.27	-96.85	-242.85
2022-03-31	344.57	-305.18	-59.44
2021-12-31	346.31	-269.06	-30.60
2021-09-30	334.59	-242.50	-67.30
2021-06-30	352.16	-243.52	-62.55
2021-03-31	274.94	-27.09	-224.96
2020-12-31	249.54	-7.86	-187.52
2020-09-30	230.69	34.04	-194.47

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Bio-Techne Corporation as of June 30, 2025 is 61.49.
The p/book for Bio-Techne Corporation as of June 30, 2025 is 4.01.
The p/tbv for Bio-Techne Corporation as of June 30, 2025 is 13.37.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30	61.49	4.01	13.37
2025-03-31		4.47	-29.78
2024-12-31		5.37	-36.75
2024-09-30	74.30	6.04	-32.56
2024-06-30	55.75	5.62	-24.93
2024-03-31		5.56	-19.94
2023-12-31	49.49	6.11	-23.48
2023-09-30	37.76	5.48	-34.35
2023-06-30	46.05	6.61	-30.87
2023-03-31	44.55	6.38
2022-12-31		7.43	-23.01
2022-09-30		6.55	-23.47
2022-06-30	60.31	7.94	-27.57
2022-03-31	80.83	10.00	-32.05
2021-12-31	115.21	12.36	-32.33
2021-09-30	135.28	12.09	-25.99
2021-06-30
2021-03-31	86.88	10.34	51.27
2020-12-31	91.31	10.44	57.05
2020-09-30	64.07	11.05	79.51

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Bio-Techne Corporation as of June 30, 2025 is 0.02.
The ebit (3y)/ev for Bio-Techne Corporation as of June 30, 2025 is 0.03.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	0.02	0.03
2025-03-31	0.02	0.03
2024-12-31	0.02	0.02
2024-09-30	0.01	0.02
2024-06-30	0.02	0.02
2024-03-31	0.02	0.02
2023-12-31	0.02	0.02
2023-09-30	0.03	0.02
2023-06-30	0.03	0.02
2023-03-31	0.03	0.02
2022-12-31	0.03	0.02
2022-09-30	0.03	0.02
2022-06-30	0.02	0.02
2022-03-31	0.01	0.01
2021-12-31	0.01	0.01
2021-09-30	0.01	0.01
2021-06-30
2021-03-31	0.01	0.01
2020-12-31	0.01	0.01
2020-09-30	0.02	0.01

Management Effectiveness

The roa for Bio-Techne Corporation as of June 30, 2025 is 0.05.
The roe for Bio-Techne Corporation as of June 30, 2025 is 0.06.
The roic for Bio-Techne Corporation as of June 30, 2025 is 0.05.
The croic for Bio-Techne Corporation as of June 30, 2025 is 0.00.
The ocroic for Bio-Techne Corporation as of June 30, 2025 is 0.11.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.05	0.06	0.05	0.00	0.11
2025-03-31	0.06	0.08	0.06	0.02	0.12
2024-12-31	0.06	0.08	0.06	0.02	0.12
2024-09-30	0.06	0.08	0.07	-0.01	0.12
2024-06-30	0.08	0.11	0.08	0.01	0.12
2024-03-31	0.09	0.12	0.09	-0.01	0.11
2023-12-31	0.10	0.14	0.10	-0.01	0.10
2023-09-30	0.12	0.17	0.12	0.00	0.11
2023-06-30	0.12	0.16	0.12	0.00	0.10
2023-03-31	0.11	0.15	0.12	-0.02	0.12
2022-12-31	0.13	0.18	0.14	-0.01	0.16
2022-09-30	0.12	0.17	0.14	-0.01	0.16
2022-06-30	0.10	0.14	0.13	-0.01	0.16
2022-03-31	0.10	0.14	0.11	-0.01	0.17
2021-12-31	0.09	0.12	0.10	0.02	0.17
2021-09-30	0.07	0.10	0.09	0.01	0.18
2021-06-30	0.07	0.10	0.07	0.03	0.18
2021-03-31	0.09	0.14	0.10	0.02	0.15
2020-12-31	0.09	0.13	0.10	0.03	0.14
2020-09-30	0.13	0.21	0.14	0.04	0.13

Gross Margins

The gross margin for Bio-Techne Corporation as of June 30, 2025 is 0.66.
The net margin for Bio-Techne Corporation as of June 30, 2025 is 0.11.
The operating margin for Bio-Techne Corporation as of June 30, 2025 is 0.18.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.66	0.11	0.18
2025-03-31	0.66	0.13	0.20
2024-12-31	0.66	0.13	0.20
2024-09-30	0.66	0.15	0.18
2024-06-30	0.67	0.18	0.21
2024-03-31	0.67	0.20	0.22
2023-12-31	0.68	0.22	0.25
2023-09-30	0.68	0.25	0.26
2023-06-30	0.68	0.25	0.26
2023-03-31	0.68	0.24	0.26
2022-12-31	0.68	0.26	0.26
2022-09-30	0.69	0.26	0.26
2022-06-30	0.68	0.25	0.27
2022-03-31	0.68	0.21	0.27
2021-12-31	0.68	0.20	0.27
2021-09-30	0.68	0.18	0.27
2021-06-30		0.15	0.26
2021-03-31	0.67	0.22	0.24
2020-12-31	0.67	0.22	0.23
2020-09-30	0.66	0.33	0.22

DE:TE1	€45.00
IT:1TECH	€45.00